Literature DB >> 2564377

Correlative study on neuro-endocrine differentiation and presence of somatostatin receptors in breast carcinomas.

M Papotti1, L Macrí, G Bussolati, J C Reubi.   

Abstract

To correlate the expression of neuro-endocrine (NE) markers with the presence of somatostatin receptors (SSR) in human breast cancer, a series of 100 cases was stained with the Grimelius silver procedure, by immunocytochemistry with specific NE markers (i.e., chromogranin A and B and synaptophysin) and by autoradiography for SSR. Nine cases were positive for at least one NE marker, while 4 cases were positive for all of them. SSR were detected in 17 cases, either with low (10 cases) or with high receptor density (7 cases). A highly significant correlation was established between the expression of NE markers and high SSR density. Our findings are additional evidence of the existence of a group of breast cancers showing morphological and cytochemical similarity with neuro-endocrine tumors present in other organs. The identification of this type of breast cancer is of biological and potential therapeutic interest.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564377     DOI: 10.1002/ijc.2910430302

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Primary neuroendocrine carcinoma of the breast: report of a case.

Authors:  Tadahiro Nozoe; Katsuo Sueishi; Emiko Mori; Tomohiro Iguchi; Akinori Egashira; Eisuke Adachi; Akito Matsukuma; Takahiro Ezaki
Journal:  Surg Today       Date:  2011-05-28       Impact factor: 2.549

Review 2.  Somatostatin receptors and their interest in diagnostic pathology.

Authors:  Marco Volante; Francesca Bozzalla-Cassione; Mauro Papotti
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

3.  The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors.

Authors:  C H van Eijck; S W Lamberts; L C Lemaire; H Jeekel; F T Bosman; J C Reubi; H A Bruining; E P Krenning
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

4.  Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analyses.

Authors:  A Pagani; M Papotti; H Höfler; R Weiler; H Winkler; G Bussolati
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

5.  Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation.

Authors:  Giordano Savelli; Alberto Zaniboni; Francesco Bertagna; Giovanni Bosio; Lutfun Nisa; Carlo Rodella; Giorgio Biasiotto; Giovanni Bettinsoli; Elena Migliorati; Alessia Peli; Roberta Falchi; Francesca Giuffrida; Raffaele Giubbini
Journal:  Breast Care (Basel)       Date:  2012-10       Impact factor: 2.860

6.  The somatostatin analog Sandostatin (SMS201-995) in treatment of DMBA-induced rat mammary tumors.

Authors:  G H Bakker; B Setyono-Han; J A Foekens; H Portengen; W L van Putten; F H de Jong; S W Lamberts; J C Reubi; J G Klijn
Journal:  Breast Cancer Res Treat       Date:  1990-11       Impact factor: 4.872

7.  Analysis of somatostatin receptor subtype mRNA expression in human breast cancer.

Authors:  A A Evans; T Crook; S A Laws; A C Gough; G T Royle; J N Primrose
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 8.  Neuroendocrine Neoplasms of the Breast: The Latest WHO Classification and Review of the Literature.

Authors:  Yukinori Ozaki; Sakiko Miura; Ryosuke Oki; Teppei Morikawa; Keita Uchino
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

9.  Invasive Breast Carcinoma with Neuroendocrine Differentiation: A Single-Center Analysis of Clinical Features and Prognosis.

Authors:  Natalia Krawczyk; Rowena Röwer; Martin Anlauf; Caja Muntanjohl; Stephan Ernst Baldus; Monika Neumann; Maggie Banys-Paluchowski; Sabine Otten; Katharina Luczak; Eugen Ruckhäberle; Svjetlana Mohrmann; Jürgen Hoffmann; Thomas Kaleta; Bernadette Jaeger; Irene Esposito; Tanja Fehm
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-11-18       Impact factor: 2.915

10.  Breast cancer cell-associated endopeptidase EC 24.11 modulates proliferative response to bombesin.

Authors:  D M Burns; B Walker; J Gray; J Nelson
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.